[English News]

ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China (prnewswire.com)

 

[Korean News]

유한양행이 점찍은 이뮨온시아, ‘5400억원’ 항암신약 기술수출 – 머니투데이 (mt.co.kr)